PATENT CLAIM ANALYSIS

Application Number: 15984918
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "401000"]

Abstract:
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.

Claim (Index 3):
The method of  claim 2 , wherein the pharmaceutical composition is in the form of a cream.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.49057
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14737360', '15429873', '13309403', '14209927', '15699692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7880583053036939
- 35 USC 102 Novelty (BERT): 0.5391232425742359
- Combined Prediction Score: 0.7631647990307482
- Mean Citation Score: 290.140902
- Max Citation Score: 382.1308
- Similarity Product: 356.145374627924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test